Batista, J. E., Kölbl, H., Herschorn, S., Rechberger, T., Cambronero, J., Halaska, M., . . . Siddiqui, E. (2015). The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: Results of a noninferiority, randomized, phase IIIb trial. Ther Adv Urol.
Citação norma ChicagoBatista, Jose E., et al. "The Efficacy and Safety of Mirabegron Compared With Solifenacin in Overactive Bladder Patients Dissatisfied With Previous Antimuscarinic Treatment Due to Lack of Efficacy: Results of a Noninferiority, Randomized, Phase IIIb Trial." Ther Adv Urol 2015.
Deismireacht MLABatista, Jose E., et al. "The Efficacy and Safety of Mirabegron Compared With Solifenacin in Overactive Bladder Patients Dissatisfied With Previous Antimuscarinic Treatment Due to Lack of Efficacy: Results of a Noninferiority, Randomized, Phase IIIb Trial." Ther Adv Urol 2015.